1. Aksoy, S., Szumlanski, C.L. and Weinshilboum, R.M. (1994): Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J. Biol. Chem., 269, 14835-14840.
2. Bhala, N., Angulo, P., van der Poorten, D., Lee, E., Hui, J.M., Saracco, G., Adams, L.A., Charatcharoenwitthaya, P., Topping, J.H., Bugianesi, E., Day, C.P. and George, J. (2011): The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology, 54, 1208-1216.
3. Browning, J.D., Szczepaniak, L.S., Dobbins, R., Nuremberg, P., Horton, J.D., Cohen, J.C., Grundy, S.M. and Hobbs, H.H. (2004): Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology, 40, 1387-1395.
4. Bryniarski, K., Biedron, R., Jakubowski, A., Chlopicki, S. and Marcinkiewicz, J. (2008): Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin. Eur. J. Pharmacol., 578, 332-338.
5. Cantoni, G.L. (1951): Activation of methionine for transmethylation. J. Biol. Chem., 189, 745-754.